Wednesday, September 16, 2026Latest filing Sep 14, 2026

Thomas H. Kean Periodic Transaction Report

Filed Nov 17, 2025 · House Clerk · 2 transactions

U.S. Representative · R · NJ-07 · All trades by Thomas H. Kean

On November 17, 2025, Rep. Thomas H. Kean (R-NJ-07) filed a periodic transaction report with the House Clerk disclosing 2 transactions (1 purchase, 1 sale) dated Oct 17, 2025 through Oct 31, 2025.

The filing covers 1 ticker, including $FISV.

Reported amount ranges sum to $101K–$265K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 31 days.

Source document: House Clerk filing 20033474

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Thomas H. Kean · Bought · Oct 17 · $100K–$250K

0.43LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.75
Cluster activityx 0.150.00
Track recordx 0.350.63

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Thomas H. Kean

Get an email the moment Thomas H. Kean files the next one. Free, no card, no spam.

Follow free →
2
Transactions
1 / 1
Buys / sells
1
Tickers
31d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Oct 17, 2025U.S. Treasury Note 4.0%, Feb. 15, 2026buy$100K–$250K31d
Oct 31, 2025FISVFiserv, Inc. (FISV)sell$1K–$15K17d

Other recent filings by Thomas H. Kean

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →